Drug products for oncology and neurological diseases will be manufactured in a second facility Johnson & Johnson plans to ...
HRV Pharma’s innovative “virtual manufacturing” model connects FDA-approved facilities to prevent prescription shortages and ...
Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout ...
AbbVie (ABBV) has agreed to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property ...
Now, the Chicago-based pharma is heading southwest as it charts the next leg of its stateside investment tour.
Novartis will invest about $70M to build a Florida radioligand therapy plant, expanding its U.S. cancer drug manufacturing ...
“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
In May 2025, the Trump administration issued an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines” directing the Food and Drug Administration (FDA) and the ...
The plant will focus on serving health care companies by developing and commercializing medical devices, drug delivery ...
This spring, the Trump administration renewed calls to bring drug manufacturing and production back to American shores, reigniting debate about what it will take to move onshoring from a lofty dream ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results